Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2000
03/09/2000WO2000012065A1 Microparticulate composition
03/09/2000WO2000012064A1 Omeprazole formulation
03/09/2000WO2000012063A1 Powdery pernasal compositions
03/09/2000WO2000012062A1 Local delivery of medications to the heart
03/09/2000WO2000012061A1 Synthetic tear fluid
03/09/2000WO2000012060A1 Electrically controlled transport of charged penetrants across barriers
03/09/2000WO2000012043A1 Improved stability for injection solutions
03/09/2000WO2000012028A1 Implantable system with drug-eluting cells for on-demand local drug delivery
03/09/2000WO2000011968A1 ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID
03/09/2000DE19853729A1 Carrier for administering medicaments to e.g. cats and dogs comprises kneadable and edible material into which pills or capsules are incorporated
03/09/2000DE19840730A1 Oil-in-water emulsions contain green tea extract and multivalent complex ligands which prevent discoloration, useful as pharmaceutical and cosmetic skin care compositions
03/09/2000DE19840489A1 Use of specified enzymes, especially lysyl oxidase, as protein crosslinking agents for formulating compositions containing active ingredients
03/09/2000DE19840256A1 Widely applicable, continuous method for preparing coated solid dosage forms, comprises extruding mixture of drug and thermoplastic binder then applying coating composition in liquid or vapor form
03/09/2000DE19840191A1 Arzneistoffhaltiges Pflaster mit drei funktionalen Schichten Drug-containing patch with three functional layers
03/09/2000DE19840152A1 Calciumvalproat enthaltende pharmazeutische Zusammensetzungen mit retardierter Wirkstoff-Freisetzung, Verfahren zu deren Herstellung und deren Verwendung Calcium valproate with delayed release pharmaceutical compositions containing the active ingredient release, methods for their preparation and their use
03/09/2000DE19839566A1 Verwendung von Fumarsäurederivaten in der Transplantationsmedizin Use of fumaric acid derivatives in transplantation
03/09/2000DE19839515A1 Association of active agent with colloidal polymer, preferably new polymeric branched polyol ester, useful for controlled transmucosal administration of e.g. peptide, DNA construct or vaccine
03/09/2000DE19838540A1 Verfahren zum Behandeln eines partikelförmigen Guts mit einem Überzugsmedium sowie Vorrichtung zur Durchführung eines derartigen Verfahrens A process for treating a particulate material with a coating medium, and apparatus for carrying out such a method
03/09/2000CA2731995A1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor
03/09/2000CA2345355A1 Electrically controlled transport of charged penetrants across barriers
03/09/2000CA2342912A1 Local delivery of medications to the heart
03/09/2000CA2342797A1 Preserved cyclodextrin-containing compositions
03/09/2000CA2342209A1 Omeprazole formulation
03/09/2000CA2342204A1 Medicinal compositions for treating eye diseases
03/09/2000CA2341908A1 Controlled release tablet comprising a hypoglycemic drug and an antihyperglycemic drug
03/09/2000CA2341810A1 Cyclic prosaposin-derived peptides and uses thereof
03/09/2000CA2341596A1 Microparticulate composition
03/09/2000CA2341454A1 Method for administering insulinotropic peptides
03/09/2000CA2341352A1 Oral vaccine compositions
03/09/2000CA2340975A1 Synthetic tear fluid
03/09/2000CA2340325A1 Alginate capsules for use in the treatment of brain tumour
03/09/2000CA2340222A1 Method for preparing spherical microparticles which consist entirely or partly of at least one water-insoluble branchings containing polyglucan, and microparticles obtainable by said method
03/09/2000CA2339823A1 Inherently antimicrobial quaternary amine hydrogel wound dressings
03/09/2000CA2247013A1 Microencapsulation or drugs
03/08/2000EP0983769A1 Permucous preparation
03/08/2000EP0983766A1 A pharmaceutical composition for the treatment of rheumatoid disorders comprising sulphur, mustard seeds and a copper salt
03/08/2000EP0983513A1 Liposomes containing oligonucleotides
03/08/2000EP0983354A2 Neurotrophic factor receptors
03/08/2000EP0983226A1 New nitromethyl ketones, process for preparing them and compositions containing them
03/08/2000EP0983088A1 Immunopotentiating composition
03/08/2000EP0983086A1 pH-SENSITIVE LIPOSOMES AND OTHER TYPES OF ENCAPSULATED VACCINES CONTAINING IMMUNOMODULATORS, AND METHODS FOR MAKING AND USING SAME
03/08/2000EP0983084A1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
03/08/2000EP0983083A1 Somatotropin compositions mixed with vitamins
03/08/2000EP0983081A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides
03/08/2000EP0983079A2 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
03/08/2000EP0983073A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
03/08/2000EP0983067A1 Benzimidazole pharmaceutical composition and process of preparation
03/08/2000EP0983065A1 Gastric-retained pharmaceutical composition
03/08/2000EP0983061A1 Methods for administering nutritional indium
03/08/2000EP0983060A1 Solid porous matrices and methods of making and using the same
03/08/2000EP0983059A1 Process for making flurbiprofen lozenges
03/08/2000EP0983058A1 Medicinal aerosol products
03/08/2000EP0983037A1 Antifungal nail lacquer and method using same
03/08/2000EP0982990A1 Stable liquid mineral ascorbate compositions and methods of manufacture and use
03/08/2000EP0946621A4 Cationic film-forming polymer compositions containing same, and uses thereof, including topical delivery system and method of delivering agents to the skin and hair
03/08/2000EP0859804B1 Water-soluble or water-dispersible polyurethanes with terminal acid groups, the production and the use thereof
03/08/2000EP0808158B1 Medicament form for the delivery of active substances to wounds
03/08/2000EP0799012B1 Method of producing coated tablets
03/08/2000EP0684806B1 Transmucosal delivery of macromolecular drugs
03/08/2000CN1246794A Lactose-free, non-hyproscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
03/08/2000CN1246791A Compositions and methods for treating or preventing inflammatory diseases
03/08/2000CN1246790A Biocompatible compounds for pharmaceutical drug delivery systems
03/08/2000CN1246369A Tissue humidifying composite and method
03/08/2000CN1246363A Medicine for treating diabets mellitus and its preparing process
03/08/2000CN1246361A Chinese medicine for preventing recurrence of drug taking
03/08/2000CN1246358A Medical capsule for treating cerebroma and its preparing process
03/08/2000CN1246352A Medical lotion for treating piles and its preparing process
03/08/2000CN1246351A Exterior-applied medicine for treating rheumatism and rheumatoid disease and its preparing process
03/08/2000CN1246350A Chinese-medicinal pill for treating toothache
03/08/2000CN1246349A Medicine for treting bony spur
03/08/2000CN1246344A Antipruritic aerosol
03/08/2000CN1246343A Snuff for treating mastopathy and its inhalator
03/08/2000CN1246342A Process for preparing garlic extract capsule
03/08/2000CN1246338A Usage and composite of agent for anti-veneral disease
03/08/2000CN1050054C Fugong instant particles for treating postpartum disease
03/08/2000CN1050052C Habit-breaking acupoint adhesive plaster for smoke
03/08/2000CN1050049C Lation for treating burn and scald
03/08/2000CN1050043C Pharmaceutical granulate
03/07/2000USRE36605 Method to clean and disinfect pathogens on the epidermis by applying a composition containing peroxidase, an iodide compound, a peroxide and a surfactant
03/07/2000US6034221 Reduced side effects
03/07/2000US6034175 Biopolymer insert
03/07/2000US6034117 Administering acetyl choline esterase inhibitor
03/07/2000US6034073 Solvent detergent emulsions having antiviral activity
03/07/2000US6034072 Genetic engineering; anticancer, antitumor agent
03/07/2000US6034061 Forming chondrocyte tissue in animal; administering bone morphogenic protein
03/07/2000US6034054 Solution containing tris buffer, arginine, zinc and preservative
03/07/2000US6033888 Process for microencapsulating cells
03/07/2000US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
03/07/2000US6033708 Blood substitutes, more specifically, a method for producing an oxygen-carrying encapsulated hemoglobin material that is sterile filterable.
03/07/2000US6033687 Blend of long lag and short lag pellets
03/07/2000US6033686 Controlled release tablet of bupropion hydrochloride
03/07/2000US6033685 Tablet for the controlled release of active agents
03/07/2000US6033683 Method of the manufacture of suppositories
03/07/2000US6033664 Use of a preparation comprising a plasminogen activator to improve wound healing
03/07/2000US6033651 Gel cosmetic compositions
03/07/2000US6033647 Crosslinked polymers of ammonium (meth)acrylate; 2-acrylamido-2-methylpropanesulfonic acid or salts, dialkylaminoalkyl (meth)acrylate, or dialkylaminoalkyl (meth)acrylamide or quaternary salts and another crosslinked
03/07/2000US6033646 Method of preparing fluorinated gas microspheres
03/07/2000US6032836 Metered dose aerosol valve
03/02/2000WO2000011023A2 Ring modified cyclic peptide analogs
03/02/2000WO2000011007A1 Carboxylated phosphatidic acid esters